NCT01124162View on ClinicalTrials.gov

Losartan 100 mg Tablets in Healthy Subjects Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

November 30, 2003

Study Completion Date

November 30, 2003

Conditions
Healthy
Interventions
DRUG

Losartan

100 mg Tablet

DRUG

Cozaar®

100 mg Tablet

Trial Locations (1)

H3X 2H9

Anapharm Inc., Montreal

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT01124162 - Losartan 100 mg Tablets in Healthy Subjects Under Fasting Conditions | Biotech Hunter | Biotech Hunter